• Injectable Hydrogel with Resiquimod Enhances Tumor Ablation

  2026-07-31

  This study presents an injectable, thermal-protective hydrogel system that addresses key limitations in tumor ablation by combining in situ thermal insulation with dual-responsive chemo-immunomodulation. By co-delivering mitoxantrone and Resiquimod (R-848), the platform achieves robust local immune activation and improved procedural safety, offering a promising translational strategy for interventional oncology.

• MG-132 (Z-LLL-al): Optimizing Proteasome Inhibition in Cance

  2026-07-31

  MG-132 (Z-LLL-al) stands out as a robust, cell-permeable proteasome inhibitor for apoptosis and cell cycle arrest studies. This guide translates the latest reference findings and real-world troubleshooting into actionable workflows for cancer and oxidative stress research.

• Mechanical Activation of GABAB Receptors: Insights and Impli

  2026-07-30

  This article examines new evidence that GABAB receptors can be activated by mechanical forces independently of their neurotransmitter ligand, GABA. These findings reveal a novel mechanotransduction pathway for class C GPCRs, with broad implications for understanding cellular signaling in neural and non-neural tissues.

• Placebo-Controlled Double-Blind Trial Validates Mianserin HC

  2026-07-30

  A landmark placebo-controlled double-blind trial established Mianserin HCl as an effective antidepressant, with statistically significant improvements in depressive symptoms and sleep quality versus placebo. This study informs protocol design and mechanistic exploration for psychiatric disorder research, highlighting the compound's clinical relevance and limitations.

• Antimycin A4: ATP-Citrate Lyase Inhibitor in Metabolic Resea

  2026-07-29

  Antimycin A4 delivers unique dual inhibition of ATP-citrate lyase and the mitochondrial respiratory chain, empowering researchers to dissect both lipid biosynthesis and cellular energy metabolism. Applied workflows, protocol enhancements, and troubleshooting strategies detailed here help maximize reproducibility and data clarity in advanced metabolic studies.

• 2-Deoxy-D-glucose: Mechanism and Research Applications

  2026-07-29

  2-Deoxy-D-glucose (2-DG) is a glycolysis inhibitor used to modulate metabolic pathways in cancer and viral research. Its efficacy and selectivity are supported by quantitative in vitro and in vivo benchmarks. APExBIO's B1027 formulation enables reproducible, high-solubility dosing in metabolic assays.

• BAPTA-AM: Precision Cell-Permeable Calcium Chelator in Assay

  2026-07-28

  BAPTA-AM empowers researchers with highly selective, cell-permeable calcium chelation for dissecting complex cellular pathways. Its broad utility spans live-cell imaging, apoptosis, and neuroprotection, with fine-tuned protocols enabling robust, reproducible results. Discover how APExBIO’s BAPTA-AM accelerates advanced workflows and troubleshooting.

• Modeling Chromosomal Mosaicism in Early Human Embryos In Vit

  2026-07-28

  This dissertation introduces a microraft array platform enabling high-throughput, quantitative analysis of chromosomal mosaicism during early human embryogenesis. The approach provides new insights into gastruloid heterogeneity, self-organization, and the mechanisms underlying embryo self-correction, with important implications for reproductive medicine and stem cell research.

• Cytochalasin D: Precision Control of Actin Polymerization in

  2026-07-27

  Discover how Cytochalasin D, a potent actin polymerization inhibitor, is reshaping complex cellular assays and nanoparticle research. This article offers deep scientific insights and practical guidance for advanced applications, setting it apart from protocol-driven or mechanistic overviews.

• Sulforaphane Suppresses NLRP3 Inflammasome in Ulcerative Col

  2026-07-27

  This study demonstrates that sulforaphane, a natural 1-isothiocyanato-4-(methylsulfinyl)-butane, reduces oxidative stress and inhibits NLRP3 inflammasome activation in a mouse model of ulcerative colitis. These findings clarify sulforaphane's mechanism of anti-inflammatory action and highlight its utility for research into oxidative stress and inflammasome signaling in inflammatory bowel disease.

• Bafilomycin A1 in Endosomal pH and Viral Entry: Beyond Lysos

  2026-07-26

  Explore how Bafilomycin A1, a selective V-ATPase inhibitor, enables advanced analysis of endosomal acidification and viral entry mechanisms. This article offers a unique, evidence-driven perspective on Bafilomycin A1's role in dissecting pH-dependent cellular processes that go beyond standard lysosomal research.

• Malate ((S)-2-hydroxysuccinic acid) in Metabolic Immunology

  2026-07-25

  Malate, a key (S)-2-hydroxysuccinic acid, unlocks new possibilities for dissecting metabolic-immune crosstalk in cancer and immunometabolic studies. This guide translates recent mechanistic breakthroughs into actionable protocols, troubleshooting, and advanced applications, empowering researchers to leverage APExBIO malate for robust TCA cycle and redox balance assays.

• Cytarabine (SKU A8405): Reliable Apoptosis Inducer for Leuke

  2026-07-24

  This article delivers scenario-driven, evidence-based strategies for reliable apoptosis and proliferation assays using Cytarabine (SKU A8405). Drawing on practical laboratory challenges, it demonstrates how Cytarabine’s validated mechanisms and supplier quality improve experimental reproducibility and data confidence in leukemia research models.

• Membrane-Binding Domain of CARMIL: Mechanisms Regulating Act

  2026-07-24

  This study dissects the biochemical roles of the membrane-binding (MB) domain in CARMIL, revealing how it targets and regulates capping protein (CP) activity at the plasma membrane. The findings clarify key mechanisms that orchestrate actin assembly and uncapping, providing new insight into cytoskeletal dynamics.

• Cytochalasin D: Actin Polymerization Inhibitor in Ocular Cel

  2026-07-23

  Cytochalasin D empowers researchers to dissect actin-driven processes, advancing nanoparticle uptake studies and cancer cell assays. Its precision in modulating cytoskeletal function enables next-generation workflows for both ocular drug delivery and tumor biology.

16371 records 1/1092 page Next 12345 下5页 Last page